We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+14.04%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.33B
AUM Growth
+$158M
Cap. Flow
+$4.07M
Cap. Flow %
0.31%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$7.63M
2
STAA icon
STAAR Surgical
STAA
+$7.5M

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$11.1M

Sector Composition

Rank Sector Weight
1 Consumer Staples 36.95%
2 Healthcare 36.24%
3 Industrials 17.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$492M 36.95%
8,295,690
-192,327
-2% -$11.1M
STAA icon
2
STAAR Surgical
STAA
$1.21B
$412M 30.97%
10,768,430
+230,595
+2% +$7.5M
AXON
3
Axon Enterprise
AXON
$42.5B
$238M 17.87%
760,062
– –
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$119M 8.94%
566,000
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$61.7M 4.63%
41,666,255
+6,730,770
+19% +$7.63M
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$7.35M 0.55%
2,509,066
– –
SER icon
7
Serina Therapeutics
SER
$30M
$1.15M 0.09%
85,219
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Broadwood Capital held 7 positions worth $1.33B, up 13% from $1.17B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 37% of assets, down from 42% a quarter earlier, followed by Healthcare and Industrials.

  • Broadwood Capital added most to Lineage Cell Therapeutics in Q1 2024, an estimated $7.63M increase.
  • Broadwood Capital's biggest Q1 2024 reduction was Monster Beverage, cutting an estimated $11.1M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.33B portfolio in Q1 2024.
  • Broadwood Capital opened 0 new positions and closed 0 in Q1 2024.
  • Broadwood Capital's portfolio value rose 13% quarter-over-quarter to $1.33B.

Based on Broadwood Capital's 13F filing for Q1 2024, filed 15 May 2024.